1. Guidance of healthcare development for metastatic cancer patients as an example for setting incentives

   • Jörg Haier
   • Jonathan Sleeman
   • Jürgen Schäfers

   Editorial 16 December 2019 Pages: 1 - 5

2. Companion canines: an under-utilised model to aid in translating anti-metastatics to the clinic

   • Louise van der Weyden
   • Mike Starkey
   • Geoffrey A. Wood

   Opinion Open access 05 November 2019 Pages: 7 - 12

3. Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond

   • Maria V. Deligiorgi
   • Mihalis I. Panayiotidis
   • Dimitrios T. Trafalis

   Review 01 October 2019 Pages: 13 - 30

   

4. Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis

   • Padacherri Vethil Jishnu
   • Pradyumna Jayaram
   • Shama Prasada Kabekkodu

   Review 07 December 2019 Pages: 31 - 46

   

5. The contribution of platelets to intravascular arrest, extravasation, and outgrowth of disseminated tumor cells

   • Amelia Foss
   • Leonel Muñoz-Sagredo
   • Wilko Thiele

   Rising Star Review 22 November 2019 Pages: 47 - 67

   

6. Tissue inhibitor of matrix metalloproteinase-3 has both anti-metastatic and anti-tumourigenic properties

   • Geetanjali P. Rai
   • Sarah K. Baird

   Molecules in Metastasis 01 January 2020 Pages: 69 - 76

7. Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis

   • Luca Nicosia
   • Vanessa Figlia
   • Filippo Alongi

   Research Paper 06 November 2019 Pages: 77 - 83

   

8. Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study

   • Mustafa S. Ascha
   • Kaitlyn Funk
   • Jill S. Barnholtz-Sloan

   Research Paper 08 November 2019 Pages: 85 - 93

   

9. Quality of life in patients with liver tumors treated with holmium-166 radioembolization

   • Caren van Roekel
   • Maarten L. J. Smits
   • Marnix G. E. H. Lam

   Research Paper Open access 15 November 2019 Pages: 95 - 105

   

10. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes

    • Austin B. Gardner
    • Lindsey M. Charo
    • John K. Chan

    Research Paper 22 November 2019 Pages: 107 - 113

    

11. Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma

    • Jiayu Zhou
    • Shizhen Zhang
    • Zhengfu He

    Research Paper 28 August 2019 Pages: 115 - 124

    

12. The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02

    • Jeong Won Lee
    • Dongryul Oh
    • Jong Hoon Lee

    Research Paper 25 September 2019 Pages: 125 - 131

    

13. Adaptation to chronic acidic extracellular pH elicits a sustained increase in lung cancer cell invasion and metastasis

    • Shusaku Sutoo
    • Toyonobu Maeda
    • Yasumasa Kato

    Research Paper Open access 05 September 2019 Pages: 133 - 144

    

14. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway

    • Hiroaki Yasui
    • Hiroaki Kajiyama
    • Fumitaka Kikkawa

    Research Paper 21 September 2019 Pages: 145 - 158

    

15. Gene expression signatures of site-specificity in cancer metastases

    • Franz Hartung
    • Aditya Patil
    • Georg F. Weber

    Research Paper 25 September 2019 Pages: 159 - 171

    

16. PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells

    • Yongming Xi
    • Zonghua Qi
    • Yan Chen

    Research Paper 30 September 2019 Pages: 173 - 185

    

17. Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer

    • Stephanie Metcalf
    • Susan Dougherty
    • Brian F. Clem

    Research Paper 19 October 2019 Pages: 187 - 197

    

18. Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model

    • Chinami Masuda
    • Masamichi Sugimoto
    • Kaname Yamamoto

    Research Paper Open access 25 November 2019 Pages: 199 - 207